In Silico Medicine: The Regulatory Gap in AI-Driven Drug Development
In silico medicine, which depends on computational modeling and simulation, is becoming more popular in drug discovery worldwide. Biomedical research is being rapidly transformed by Artificial Intelligence (AI), but there are risks associated with regulatory ambiguity. The integration of AI offers significant oppor...